Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $78,841
97%  
Woo hoo!! And we're now over 97%!! Thank you all very much!! God bless.

Keyword: baricitinib

Brevity: Headers | « Text »
  • Current Use of Baricitinib in COVID-19 Treatment and Its Future: An Updated Literature Review

    12/05/2024 10:50:33 AM PST · by ducttape45 · 6 replies
    I believe there was a post regarding this topic/drug on FR a few weeks/months back, but I wondered if anyone has heard of research to determine the effectiveness of using Baricitinib to treat Long Covid? There were a few articles regarding this topic that I had bookmarked but now the webpages are gone. Convenient huh? I'm interesting in finding out if anyone here has any information on this. Thank you all for your time.
  • WHO strongly recommends Arthritis drug for severe COVID-19

    02/04/2022 11:23:32 AM PST · by CondoleezzaProtege · 33 replies
    Medical News Today ^ | Jan 2022 | James Kingsland
    The WHO has strongly recommended that doctors use an arthritis drug called baricitinib to treat people with severe or critical COVID-19. The drug belongs to a class of medications known as Janus kinase (JAK) inhibitors, which block the activity of immune signaling molecules called cytokines. In severe and critical COVID-19, an excess of cytokines in the body, or “cytokine stormTrusted Source,” sends the immune system into overdrive, with potentially fatal consequences. After reviewing the latest results from clinical trials, a panel of experts at the WHO concluded that there is good evidence that baricitinib improves survival, reduces the need for...
  • Arthritis Drug ‘Will Save Thousands’ Of Covid-19 Patients After Excellent Trial Results

    09/03/2021 7:52:10 PM PDT · by Fractal Trader · 67 replies
    Forbes ^ | 1 September 2021 | Victoria Forster
    A drug used to treat rheumatoid arthritis has been found to improve survival of hospitalized Covid-19 patients. The discovery comes from a study of over 1,500 Covid-19 patients in 12 countries and is being hailed as a significant breakthrough for treatment options for people who are severely ill with Covid-19. Early on in the pandemic in February 2020, baricitinib was identified as a promising drug to treat Covid-19 by a company using artificial intelligence (AI) and machine learning to identify potential treatments for diseases. The drug, normally used to treat rheumatoid arthritis, was thought to have possible antivirus properties, but...